Overview

Bisoprolol in Hypertension: Effect on Concomitant Elevated Heart Rate

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The b.p.m study will be performed to gain the insight in the courses of illness and therapy in subjects, suffering from hypertension and that have elevated heart rate. This study will show that a therapy with bisoprolol (Concor/Concor PLUS) or any other blood pressure lowering (antihypertensive) drug lowers blood pressure (BP) and heart rate and increases the quality of subjects' life.
Details
Lead Sponsor:
Merck KGaA
Merck KGaA, Darmstadt, Germany
Collaborator:
Merck Gesellschaft mbH, Austria
Treatments:
Bisoprolol